TATIANA HURTADO: Open Payments
NPI 1003457565 · SACRAMENTO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,296 in 94 payments from 15 companies in 2025. Trend: 2023 $457 · 2024 $2,142 · 2025 $2,296
Food & beverage: $2,196Education: $100
| Company | Payments | Amount |
|---|---|---|
| Arcutis Biotherapeutics, Inc. | 13 | $407 |
| GENZYME CORPORATION | 10 | $370 |
| Incyte Corporation | 18 | $343 |
| Janssen Biotech, Inc. | 7 | $307 |
| Verrica Pharmaceuticals Inc. | 23 | $175 |
| Regeneron Healthcare Solutions, Inc. | 3 | $173 |
| Janssen Scientific Affairs, LLC | 1 | $124 |
| Novartis Pharmaceuticals Corporation | 3 | $82 |
| Lilly USA, LLC | 3 | $71 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $51 |
Products named: DUPIXENT, TREMFYA, OPZELURA, Zoryve, YCANTH, COSENTYX, Winlevi, NEMLUVIO.
Industry payments across CA — which companies pay providers there.
